BIOLASE, Inc. (BIOL)

BIOLASE Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-21.27	-20.63	-28.63	-16.16	-16.83	-17.86
Depreciation & Amortization	3.31	2.8	0.5	0.4	0.5	0.98
Share-Based Compensation	0.65	1.23	2.3	1.66	3.37	2.74
Other Operating Activities	2.93	2.51	-0.93	-2.61	0.17	1.39
Operating Cash Flow	-14.37	-14.09	-26.76	-16.71	-12.8	-12.75
Capital Expenditures	-0.7	-1.31	-3.73	-0.71	-0.1	-0.21
Acquisitions	0.38	0.18	0	0	0	0
Other Investing Activities	-0.03	-	-	-	-	-
Investing Cash Flow	-0.35	-1.13	-3.73	-0.71	-0.1	-0.21
Common Stock Issued	14.89	17.6	5.6	29.98	6.91	9.17
Share Repurchases	0	0	0	0	17.38	0
Other Financing Activities	-0.33	-0.17	-1	-0.03	34.82	1.55
Financing Cash Flow	14.56	17.43	4.6	29.95	24.35	10.72
Net Cash Flow	-0.14	2.39	-25.99	12.3	11.78	-2.26
Free Cash Flow	-15.07	-15.4	-30.49	-17.42	-12.89	-12.95
Free Cash Flow Margin	-30.86%	-31.33%	-62.91%	-44.44%	-56.59%	-34.27%
Free Cash Flow Per Share	-0.84	-12.05	-439.94	-294.71	-527.15	-1395.74

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.